April 2, 2013 / 11:59 AM / 4 years ago

CORRECTED-Obagi Medical gets higher offer from Merz Pharma

1 Min Read

(Corrects paragraph 1 to say Obagi is a cosmetic products maker, not a laser device maker)

April 2 (Reuters) - Neurological and dermatology drugs maker Merz Pharma Group offered to buy cosmetic products maker Obagi Medical Products Inc for $383.5 million, topping a bid by Canada's Valeant Pharmaceuticals International Inc last month.

Merz's offer of $22 per share represents a premium of 11 percent to Valeant's offer of $19.75. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below